GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mono Pharmacare Ltd (NSE:MONOPHARMA) » Definitions » ROA %

Mono Pharmacare (NSE:MONOPHARMA) ROA % : 5.08% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mono Pharmacare ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Mono Pharmacare's annualized Net Income for the quarter that ended in Sep. 2024 was ₹46 Mil. Mono Pharmacare's average Total Assets over the quarter that ended in Sep. 2024 was ₹903 Mil. Therefore, Mono Pharmacare's annualized ROA % for the quarter that ended in Sep. 2024 was 5.08%.

The historical rank and industry rank for Mono Pharmacare's ROA % or its related term are showing as below:

NSE:MONOPHARMA' s ROA % Range Over the Past 10 Years
Min: 0.85   Med: 2.97   Max: 3.4
Current: 3.36

During the past 4 years, Mono Pharmacare's highest ROA % was 3.40%. The lowest was 0.85%. And the median was 2.97%.

NSE:MONOPHARMA's ROA % is ranked better than
61.01% of 690 companies
in the Healthcare Providers & Services industry
Industry Median: 1.425 vs NSE:MONOPHARMA: 3.36

Mono Pharmacare ROA % Historical Data

The historical data trend for Mono Pharmacare's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mono Pharmacare ROA % Chart

Mono Pharmacare Annual Data
Trend Mar21 Mar22 Mar23 Mar24
ROA %
0.85 2.74 3.20 3.40

Mono Pharmacare Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
ROA % Get a 7-Day Free Trial 8.27 2.03 5.41 1.48 5.08

Competitive Comparison of Mono Pharmacare's ROA %

For the Pharmaceutical Retailers subindustry, Mono Pharmacare's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mono Pharmacare's ROA % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's ROA % distribution charts can be found below:

* The bar in red indicates where Mono Pharmacare's ROA % falls into.



Mono Pharmacare ROA % Calculation

Mono Pharmacare's annualized ROA % for the fiscal year that ended in Mar. 2024 is calculated as:

ROA %=Net Income (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=24.424/( (626.025+811.127)/ 2 )
=24.424/718.576
=3.40 %

Mono Pharmacare's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=45.858/( (811.127+995.159)/ 2 )
=45.858/903.143
=5.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


Mono Pharmacare  (NSE:MONOPHARMA) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=45.858/903.143
=(Net Income / Revenue)*(Revenue / Total Assets)
=(45.858 / 1743.256)*(1743.256 / 903.143)
=Net Margin %*Asset Turnover
=2.63 %*1.9302
=5.08 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Mono Pharmacare ROA % Related Terms

Thank you for viewing the detailed overview of Mono Pharmacare's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mono Pharmacare Business Description

Traded in Other Exchanges
N/A
Address
1A, Krinkal Apartment, Opp. Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007
Mono Pharmacare Ltd is a distributor and supplier of a wide array of Pharmaceuticals products and medicines. The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac-Diabetic medicines, and cosmocare products.

Mono Pharmacare Headlines

No Headlines